ICU Medical (ICUI) Financials

$156.48

$-0.78 (-0.50%)

As on 11-Sep-2026 16:00EDT

Market cap

$3,913 Mln

Revenue (TTM)

$2,159 Mln

P/E Ratio

131.5

P/B Ratio

1.8

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	2,159.36	2,230.03	2,382.05	2,259.13	2,280.00	1,316.31
Cost of Revenue	1,348.20	1,410.37	1,557.26	1,519.25	1,582.24	824.82
Gross Profit	811.16	819.66	824.78	739.87	697.76	491.49
Operating Expenses	702.41	712.71	781.82	717.05	740.66	368.25
Operating Profit (EBIT)	108.76	106.95	42.96	22.83	-42.90	123.25
Other Income	--	--	--	--	--	0.80
Profit before Tax	-3.88	3.17	-66.01	-78.30	-114.41	123.19
Provision for Tax	-30.96	2.44	51.68	-48.64	-40.12	20.05
Profit after Tax (Net Income)	30.09	0.73	-117.69	-29.66	-74.29	103.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-74.29	103.14

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	2,151.85	2,123.82	1,965.24	2,123.41	2,089.93	1,616.03
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1,321.07	1,427.82	1,682.51	1,773.19	1,931.15	63.93
Current Liabilities	498.36	498.86	556.18	481.84	494.56	200.78
Total Liabilities	4,469.65	4,050.51	4,203.93	4,378.44	4,515.64	1,880.74

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	2,760.37	2,859.95	2,761.95	3,157.17	3,280.45	850.93
Current Assets	1,210.91	1,177.44	1,441.98	1,221.27	1,235.20	1,029.81
Total Assets	4,469.65	4,050.51	4,203.93	4,378.44	4,515.64	1,880.74
Total Debt*	1,271.57	1,392.22	1,641.66	1,703.86	1,734.30	45.05
Net Current Assets	712.54	691.69	885.80	739.43	740.64	829.03

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	179.85	204.03	166.20	-62.13	267.54
Cash Flow from Investing Activities	--	122.23	-88.96	-87.95	-1,909.47	-90.69
Cash from Financing Activities	--	-311.53	-55.80	-35.98	1,637.03	-16.87
Net Cash Inflow / Outflow	--	--	--	--	--	156.73

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.18	0.03	-4.81	-1.23	-3.10	4.73
Cash EPS ($)	1.19	8.16	4.16	8.25	6.71	8.84
Adjusted Book Value ($)	86.05	86.03	80.24	87.96	87.12	74.11
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	7.29	8.33	6.88	-2.59	12.27
Free Cash Flow per Share ($)	--	3.72	5.09	3.00	-6.73	8.55

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	0.02	-3.17	-0.78	-2.71	6.41
ROE (%)	1.41	0.04	-5.76	-1.41	-4.01	6.61
ROA (%)	0.66	0.02	-2.74	-0.67	-2.32	5.66
EBIT Margin (%)	1.98	4.87	1.70	1.08	-1.91	9.43
Net Margin (%)	1.39	0.03	-4.94	-1.31	-3.26	7.83
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	-8.98	-0.06	0.05	-0.01	0.73	0.04
EBIT Growth (%)	-62.71	167.83	65.91	156.02	-135.12	25.11
Net Profit Growth (%)	181.43	100.62	-296.86	60.08	-172.03	18.72
EPS Growth (%)	177.73	1.01	-2.91	0.60	-1.65	0.18
Book Value Growth (%)	0.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	131.50	4,811.60	-32.29	-81.19	-50.85	50.18
Price / Book Value	1.83	1.66	1.93	1.13	1.81	3.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	17.26	14.11	119.46	15.23	27.66	20.82
Close Price ($)	146.60	142.67	155.17	99.74	157.48	237.34
High Price ($)	160.29	175.51	196.26	212.43	251.73	282.00
Low Price ($)	107.00	107.00	86.80	78.28	128.90	183.39
Market Cap ($ Cr)	3,913.10	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.56	0.66	0.84	0.80	0.83	0.03
Short term debt to equity ratio	0.01	0.02	0.03	0.03	0.02	0.01
Current Ratio	2.43	2.36	2.59	2.53	2.50	5.13
Quick Ratio	1.21	1.13	1.54	1.06	1.09	3.68
Interest Coverage	0.95	1.03	0.38	0.24	-0.62	144.72

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	10.13	8.09	8.51	8.06	10.83	9.48
Asset Turnover	0.48	0.54	0.56	0.51	0.71	0.72
Receivable days	--	31.38	29.50	34.68	29.77	35.04
Inventory Days	--	155.45	151.76	168.94	113.83	133.99
Payable days	--	39.16	34.95	43.99	34.28	33.87
Cash Conversion Cycle	--	147.68	146.31	159.63	109.32	135.16

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)